gw420867x has been researched along with dpc 961 in 1 studies
| Studies (gw420867x) | Trials (gw420867x) | Recent Studies (post-2010) (gw420867x) | Studies (dpc 961) | Trials (dpc 961) | Recent Studies (post-2010) (dpc 961) |
|---|---|---|---|---|---|
| 17 | 5 | 2 | 15 | 0 | 2 |
| Protein | Taxonomy | gw420867x (IC50) | dpc 961 (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.032 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.0474 | |
| Protease | Human immunodeficiency virus 1 | 0.031 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastos, MM; Bezerra, TC; Boechat, N; Costa, CCP; da Silva, FC | 1 |
1 review(s) available for gw420867x and dpc 961
| Article | Year |
|---|---|
Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Chemistry, Pharmaceutical; Cyclopropanes; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Conformation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2016 |